See Also (Topic, Algorithm, Electronic Media Element)
Seizures
CODES
ICD9
- 320.2 Streptococcal meningitis
- 320.9 Meningitis due to unspecified bacterium
- 322.9 Meningitis, unspecified
ICD10
- G00.2 Streptococcal meningitis
- G00.9 Bacterial meningitis, unspecified
- G03.9 Meningitis, unspecified
MENINGOCOCCEMIA
Brian D. Euerle
BASICS
DESCRIPTION
- Bacterial illness caused by
Neisseria meningitidis
- Several forms of illness may occur
- Mild meningococcemia
- Overwhelming meningococcal sepsis
- Meningococcal meningitis
- Chronic/occult meningococcemia
- Septic arthritis
- Acquired from close contact with an infected individual or an asymptomatic carrier
- Intimate kissing and cigarette smoking are independent risk factors.
ETIOLOGY
- N. meningitidis
:
- Serotypes A, B, C, D, H, I, K, L, X, Y, Z, 29E, and W135
- Serotype B is most common in US
- Majority of infections caused by A, B, C, X, Y, and W135
- Bacteria attach to and enter nasopharyngeal epithelial cells.
- Bacteria spread from the nasopharynx through the bloodstream via entry of vascular endothelium.
- Most circulating meningococci are eliminated by the spleen.
- Meningococci produce an endotoxin (lipooligosaccharide):
- Involved in pathogenesis of the skin, adrenal manifestations, and vascular collapse
- Human oropharynx/nasopharynx is the only reservoir.
- Carrier usually has developed immunity to serotype-specific antibody (not immune to all serotypes):
- Age <5 yr: 1% carrier rate
- Age 20–40 yr: 30–40% carrier rate
- Lower rate of immunity in children, which is reflected by the higher rates of infection
- Most common in fall and spring
- Increased incidence in military recruits and close living conditions
- Epidemics—ages 5–9 yr most/earliest affected
DIAGNOSIS
SIGNS AND SYMPTOMS
- “Mild” meningococcemia:
- Most common
- Preceded by upper respiratory infection
- Fever, chills, myalgias/arthralgias, malaise
- Often self-limited, resolving in several days
- Can progress to meningitis (mortality rate 2–10%) or overwhelming sepsis without meningitis
- Overwhelming meningococcal sepsis:
- 10% of overall meningococcemia cases
- High mortality rate (20–60%)
- Most deaths occur in 1st 48 hr
- Sudden onset of illness and rapid progression of clinical course
- Initial presentation may be mild:
- Mild tachycardia
- Mild tachypnea/respiratory symptoms
- Mild hypotension
- Fever, chills, vomiting, headache, rash, muscle tenderness
- Toxic appearing
- Infants: Lethargy, poor feeding, bulging fontanel
- Rash:
- Combination of purpura/ecchymosis
- May later exhibit coalescence, necrosis/sloughing of the involved skin (purpura fulminans)
- Petechiae (over skin, mucous membranes, conjunctivae) seen in 50–60%
- Macules
- Papules (scrapings of papules demonstrate the organism on Gram stain)
- Deteriorate quickly over several hours:
- Hypotension/shock
- Acidosis
- Acute respiratory distress syndrome (ARDS)
- Disseminated intravascular coagulation (DIC)
- Meningitis may or may not be present.
- Waterhouse–Friderichsen syndrome:
- Bilateral hemorrhagic destruction of adrenal glands
- Vasomotor collapse
- Acute renal failure:
- From prolonged hypotension (low renal perfusion causing acute tubular necrosis)
- Chronic meningococcemia:
- Uncommon
- Well appearing
- Recurrent fevers, chills, arthralgias over weeks to months
- Intermittent rash—painful on the extremities
- Migratory polyarthritis
- Splenomegaly (20%)
- Meningococcal meningitis:
- Headache
- Fever
- Neck stiffness
- Confusion
- Lethargy
- Obtundation
- Septic arthritis:
- Occurs during active meningococcemia
- Multiple joints involved
- Joint pain, redness, swelling, effusion, fever, chills
- Extremely limited or no range of motion
- Other meningococcal infections:
- Occur with meningococcal infection elsewhere
- Conjunctivitis—may occur alone
- Sinusitis
- Panophthalmitis
- Urethritis
- Salpingitis
- Prostatitis
- Pneumonia
- Myocarditis/pericarditis:
- Occurs late in onset
- Usually associated with serogroup C
History
Progression of illness is variable and classifies illness into mild, overwhelming, and chronic.
Physical-Exam
- Tachycardia
- Hypotension, which may be mild initially
- Progressive, rapid deterioration
- Respiratory failure with ARDS picture
- Petechial rash 50–80%:
- Involves axillae, flanks, wrists, ankles
ESSENTIAL WORKUP
- Do not allow workup (including delay in lumbar puncture) to postpone resuscitation and administration of antibiotics in suspected cases of meningococcemia.
- Suspect diagnosis in setting of dramatic clinical presentation.
- Gram stain and culture of:
- Peripheral blood, CSF, sputum, urine, joint aspirate, or petechial/papular scrapings
- Gram stain: Intracellular or extracellular gram-negative diplococci
DIAGNOSIS TESTS & NTERPRETATION
Lab
- CBC:
- Elevated WBCs initially; later may be suppressed in severe disease
- Decreased platelet count when large areas of purpura/petechiae or DIC
- Electrolytes, BUN, creatinine, glucose
- CSF:
- Gram stain, culture, protein and glucose, cell count with differential
- Consistent with bacterial infection in meningococcal meningitis
- Arterial blood gases for acidosis, hypoxia
- Fibrinogen levels, fibrin degradation products, prothrombin time, partial thromboplastin time if DIC suspected
- Throat/nasopharyngeal swab:
- Positive swab does not establish the diagnosis of meningococcemia.
- Analysis of buffy-coat layer of peripheral blood for bacteria if sepsis is suspected
- Blood culture:
- Often negative with chronic meningococcemia
- Positive in mild and overwhelming meningococcemia
- Immunoassays (beware false negatives)
- Polymerase chain reaction, especially useful when antibiotics given before specimen collection
Imaging
CXR: For ARDS/pneumonia
Diagnostic Procedures/Surgery
Amputations and débridement of necrotic tissue and/or extremities may be necessary.
DIFFERENTIAL DIAGNOSIS
- Viral exanthem
- Vasculitis
- Mycoplasma
- Rocky Mountain spotted fever
- Toxic shock syndrome
- Henoch–Schönlein purpura
- Idiopathic thrombocytopenic purpura
- Dengue fever
- Disseminated gonococcal infection
- Influenza
- Streptococcus
group A and B
- Thrombotic thrombocytopenic purpura
TREATMENT